Parallax Volatility Advisers, L.P. Bridge Bio Pharma, Inc. Transaction History
Parallax Volatility Advisers, L.P.
- $35.7 Billion
- Q1 2025
A detailed history of Parallax Volatility Advisers, L.P. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 25,000 shares of BBIO stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,000
Previous 15,629
59.96%
Holding current value
$1.03 Million
Previous $428,000
101.87%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BBIO
# of Institutions
362Shares Held
185MCall Options Held
12.8MPut Options Held
2.09M-
Viking Global Investors LP22.1MShares$907 Million2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$792 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$613 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$512 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$295 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $6.1B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...